16536-89-3 ((L-ADRENALINE BITARTRATE)

L-ADRENALINE BITARTRATE;(2R,3R)-2,3-dihydroxybutanedioic acid,4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;(-)-Epinephrine (+)-bitartrate salt, solid;HY-B0447A;D02149;l-Epinephrine bitartrate;Medihaler-epi (TN);adrenalinium;l-Epinephrine tartrate;BCP9000650;Epinephrine acid tartrate;l-Adrenaline hydrogen tartrate;Adrenaline tatrate;Epinephrine Bitartrate, Pharmaceutical Secondary Standard; Certified Reference Material;EPINEPHRINE BITARTRATE (USP MONOGRAPH);Bronitin Mist;16536-89-3;(-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur.;L-epinephrine hydrogen tartrate;4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (2R,3R)-2,3-dihydroxybutanedioate (1:1);L-Epinephrine D-hydrogentartrate;EPINEPHRINE BITARTRATE [WHO-DD];ADRENALINE TARTRATE (EP MONOGRAPH);Bronkaid Mist Suspension;CAS-51-42-3;CCG-267841;Q27255971;Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-;(-)-Adrenaline tartrate;Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard;(-)-Adrenaline bitartrate;EPINEPHRINE BITARTRATE COMPONENT OF LIGNOSPAN FORTE;NSC 756755;Epinephrine bitartrate;Tox21_202839;(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;BCP0726000242;24351-82-4;Adrenaline (as tartrate);EPINEPHRINE BITARTRATE [ORANGE BOOK];ADRENALINE ACID TARTRATE [MART.];Adrenaline acid tartrate;EPINEPHRINE HYDROGEN TARTRATE [WHO-IP];Adrenaline hydrogen tartrate;L-Epinephrine (Bitartrate);(-)-3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)BENZYL ALCOHOL (+)-TARTRATE (1:1) SALT.;SCHEMBL40741;EPINEPHRINE BITARTRATE [VANDF];(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate;(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt;Adrenalinetartrate;CHEMBL1200818;ADRENALINE ACID TARTRATE (MART.);EPINEPHRINI HYDROGENOTARTRAS [WHO-IP LATIN];(-)-Epinephrine bitartrate;(-)-Epinephrine (+)-bitartrate salt;Primatene Mist Suspension;1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt);Epinephrine bitartrate [USP:JAN];AKOS015951390;(-)-Adrenaline acid tartrate;Adrenaline Tartrate (L-Adrenaline Tartrate);l-Adrenaline d-bitartrate;ADRENALINE TARTRATE [EP MONOGRAPH];EPINEPHRINE BITARTRATE [USP MONOGRAPH];1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt);ADRENALIN TARTRATE [WHO-IP];30Q7KI53AK;NCGC00260385-01;Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard;epinephrinehydrogentartrate;L-Adrenaline tartrate;EINECS 200-097-1;NSC-756755;Adrenalin tartrate;Adrenaline bitartate;EPINEPHRINE D-BITARTRATE [MI];Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard;EN300-12578730;(R)-(-)-Epinephrine bitartrate;(-)-Epinephrine-(+)-bitartrate;s2521;Adrenaline bitartrate;Adrenaline acid tartrate, British Pharmacopoeia (BP) Reference Standard;(-)-Epinephrine (+)-bitartrate;51-42-3;DTXCID2029375;Epinephrine bitartrate (JAN/USP);EPINEPHRINE BITARTRATE (USP-RS);EPINEPHRINE TARTRATE;Epinephrine bitartrate (USP:JAN);Epinephrine bitartrate (Adrenalinium);(-)-Adrenaline hydrogen tartrate;Epinephrine d-bitartrate;1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt);SW219274-2;Bronitin;Asthmahaler;DTXSID3049415;EPINEPHRINE BITARTRATE [USP-RS];Asmatane mist (TN);(2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;adrenaline tartrate;D88223;HMS3884F06;Adrenaline acid tartrate, l-;UNII-30Q7KI53AK;LIGNOSPAN FORTE COMPONENT EPINEPHRINE BITARTRATE;EPINEPHRINE BITARTRATE [JAN];l-Epinephrine d-bitartrate;CHEBI:228805;

YLXIPWWIOISBDD-NDAAPVSOSA-N

1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1

O[C@@H](CNC)C1C=CC(=C(C=1)O)O.O[C@@H](C(=O)O)[C@H](C(=O)O)O